1. Introduction
Amblyopia in humans is associated with decreased visual functions due to abnormal binocular interaction during the development of the visual system [
1], and it affects approximately 2% of the population [
2]. Often, these decreased visual functions are discussed in terms of monocular visual acuity deficits, though other deficits exist in amblyopia that are both monocular and binocular in nature. Binocular deficits include excessive interocular suppression of the amblyopic eye and reduced stereoacuity [
1,
3,
4,
5,
6,
7,
8,
9]. The importance of addressing suppression to understand amblyopia has received much attention in the recent literature. Psychophysical studies have shown that implementing binocular perceptual learning protocols to reduce the suppression of the amblyopic eye resulted in improved visual functions [
10,
11]. Although suppression is often measured clinically, its outcome is usually recorded in a binary manner (yes/no). This is because the tests that evaluate suppression do not readily lend themselves to precise measurements of suppression magnitudes. A common clinical test for suppression is the Worth 4 Dot test [
12], but it lacks precision for quantifying the amount of suppression. Often, clinicians use ambient lighting as a measure of suppression, noting that if a patient suppresses in both a bright and dim room, the suppression is deep, while if he/she only suppresses in a bright room, the suppression is shallow [
8]. Even when a filter is used in conjunction with the Worth 4 Dot test, the dissociative nature of the red green filters (that create the dichoptic viewing conditions necessary to evaluate suppression) can give rise to artifacts in fusion responses [
13].
More sensitive measurements of suppression using standard psychophysical methods exist within the laboratory setting. These include tests with global motion and spatial pattern stimuli [
14], with binocular rivalry stimulus [
10,
15,
16,
17,
18], and with binocular phase combination stimulus [
19,
20,
21]. While these tests provide the precise quantification of suppression depth, they are not readily accessible to clinicians because they require an elaborate hardware and software setup. Thus, a gap remains as to how clinicians can precisely quantify suppression depth in a manner akin to the stricter laboratory measures. Given the important role of suppression in amblyopia, it is more imperative now for clinicians to quantify suppression, in addition to visual acuity. Knowing the extent of suppression provides a useful index for diagnosing the severity of amblyopia and for monitoring the recovery progress during amblyopia therapy. Other researchers have recommended procedures that can be completed clinically to quantify suppression using different computer-based technologies [
22,
23]. There is also a novel eye movement analysis that provides insight into stereopsis, binocular summation, and suppression through the measurement of the Ocular Following Responses that negates the need for subjective responses from patients [
24,
25]. While the outcomes from these studies provide promising results for the field of amblyopia, they are currently limited in use and require specialized equipment.
We propose that the Synoptophore could be used as the instrument to bridge the gap between laboratory and clinic. The earliest Synoptophore was constructed by William Ettles in 1912. It was based on a haploscopic design of the Amblyoscope invented by Claud Worth and constructed by AW Haws in 1895 and later modified by Nelson Black in 1906 [
26]. Worth proposed three sequential levels of binocular visual abilities, which he referred to as first, second, and third degrees of fusional abilities (to be described more in Methods) [
12]. This concept of three degrees of fusion lays the foundation for clinical testing with the Synoptophore. Today, the Synoptophore is a commercially available instrument present in many Binocular Vision clinics. The Synoptophore does not use dissociative filters, providing for a more naturalistic viewing that may better gauge how patients operate binocularly in their everyday world [
27]. It also provides for the independent manipulation of each eye’s stimulus illumination, whereby the amblyopic eye’s target intensity can be boosted, while the fellow eye’s target intensity is diminished via a rheostat mechanism that controls the brightness of the light bulbs used to illuminate the dichoptic targets. Performing this allows the clinician to balance the strength of the two eyes to obtain an estimate of the depth of suppression of the amblyopic (weak) eye, in a manner similar to conventional psychophysical measurements [
15,
16,
28,
29,
30,
31].
While manipulation of the instrument’s rheostats has been used for decades [
32], a systematic protocol has not been implemented nor have the illumination settings been published to provide meaningful quantification of suppression (Haag-Streit UK was unable to provide us with the illuminance values (personal communication)). Thus, in terms of illuminance control, the Synoptophore measures provide a little more information than the previously mentioned Worth 4 Dot. To address this deficiency and extend the utility of the Synoptophore, the current study measured the illuminance levels of the Synoptophore at the various rotatory knob settings. This allowed us to precisely quantify the depth of suppression, thus making the measurement more comparable with laboratory measurements of suppression. The ability to quantify suppression also permitted us to measure the magnitude of suppression with Worth’s first- and second-degree fusional targets. In fact, the concept-driven design of the Synoptophore targets, which allows for the classification of successive levels of binocular fusion abilities, provides a clear advantage for quantifying suppression over the Worth 4 Dot test, which is considered a second-degree target with very rudimentary fuse-able contours. Additionally, the commercially manufactured slides used for the present study are printed in a variety of sizes that allows for testing the same target features at different visual angles while maintaining a set viewing distance. Worth 4 Dot is typically tested at different distances to alter the visual angle of the target, making it difficult to precisely control for accommodation, eye alignment, and the visual angle itself. The objective of our study was to design a protocol for measuring suppression in amblyopia with the commercially manufactured Synoptophore and corresponding slides. This would allow for clinicians to measure their patients’ suppression in more precise detail, using equipment they already have available for testing. To provide reassurance that our protocol is suitable for clinical needs, we set out to validate our protocol through comparison to the current clinical standard of Worth 4 Dot. Separately, we tested our subjects’ visual acuity and stereopsis to compare with the suppression magnitudes obtained with the Synoptophore.
2. Methods
The research reported herein conformed with the tenets of the Declaration of Helsinki and was approved by The Ohio State University’s Institutional Review Board. Subjects provided written informed consent prior to study participation.
2.1. Participants
Twenty-six adult subjects participated in our study, all of whom had been previously treated for amblyopia with varying levels of compliance and success. The average age of the subjects was 27.5 ± 5.5 years, and 65% were female. For simplicity, we refer to our subjects as amblyopic given their history and current binocular deficiencies. Additionally, to be considered for analyses, subjects had to have a best-corrected interocular difference in visual acuity of 0.2 logMAR or more (visual acuity testing is described in further detail below). All testing was conducted with subjects wearing lenses (either habitual eyeglasses or trial frames) that corrected for their anisometropia, as determined by cycloplegic retinoscopy, within 0.50 D. Please refer to
Table 1 for details of each subject.
We classified amblyopia based upon suspected origin. Subjects without a constant unilateral strabismus whose amblyopia was caused by anisometropia were categorized as “Aniso,” even if an intermittent strabismus was also present, which occurred at the near test viewing distance in a few subjects. Subjects with a constant unilateral strabismus were grouped into the “strabismic” amblyopia group, even if anisometropia was also present. No subjects were included with coexisting ocular pathology.
2.2. Synoptophore
2.2.1. Apparatus
Testing of suppression was performed on the Haag-Streit Synoptophore, 2001 model (Haag-Streit, Koniz, Switzerland). The Synoptophore has two separate slide mounts that are projected to each eye through separate moveable tubes, utilizing a mirror at the bend of the tube and a + 6.50 DS lens to simulate distance viewing. Each target slide was illuminated by the supplied Eveready Clear Capsule G4 20 W Halogen Bulb (Energizer Holdings, St. Louis, MO, USA) that was controlled by a rheostat ranging from 0 to 10, with markings for every integer. A T-10MA Illuminance Meter (Konica Minolta, Ramsey, NJ, USA) was used to measure the radiometric brightness of the Synoptophore at each integer setting (0–10, 11 settings total) through each target slide (described below with examples depicted in
Figure 1). An overall log-linear progression of illumination was found in between settings, such that each increase in a setting on the rheostat resulted in an approximately 0.15 log unit increase in brightness. This log-linear relationship is depicted in
Figure 2, where a significant correlation (
rP = 0.997,
p = 0.001) exists between Synoptophore setting and illuminance.
2.2.2. Stimuli
Target slides for our study were commercially made by Haag-Streit and fell into the simultaneous perception and flat fusion categories of Worth’s three fusion levels. The simultaneous perception slides, referred to throughout the rest of the paper as first-degree targets, pictured in
Figure 1A, were a pair of dissimilar objects (a soldier and a house). The flat fusion slides, referred to throughout the rest of the paper as second-degree targets, pictured in
Figure 1B, were a pair of similar objects (to promote fusion) tagged with different features (serving as suppression checks) presented to each eye (a rabbit with flowers and a rabbit with a tail). These particular stimuli were chosen as they are manufactured in a variety of sizes. The angular sizes of the three soldiers were, respectively, 12 × 2.5°, 7.5 × 1.5°, and 2.5 × 0.5°, and the angular sizes of the three rabbits were, respectively, 11 × 11°, 7 × 7°, and 2.5 × 2.5°.
2.3. Measurement of Depth of Suppression with the Synoptophore
Depth of suppression was measured when subjects reported simultaneous perception with the first-degree targets or fusion with the second-degree targets. To achieve this, the dichoptic targets were initially placed at the subject’s objective angle (determined as the position where alternating illumination resulted in no movement of either eye) and then fine-tuned with some subjective input (subjects reported whether images were diplopic at the objective angle, and adjustments were made until single vision was obtained). A simultaneous perception response was determined when the subject saw the soldier centered in the house. A flat fusion response was determined when all suppression checks were visible and aligned with second-degree targets (e.g., a single rabbit with a tail holding flowers). Each dichoptic target was initially illuminated with setting “5” on its corresponding rheostat (rotatory knob). Illumination was then altered to find the setting for each eye in which it was easier to “focus on”, “attend to”, or “see with equal ease” features from both eyes’ targets. For example, with the first-degree slides, a subject might report the soldier’s hat was “flickering in and out” during the one setting and appeared “more stable” during another. In this example, the rheostat settings in which the soldier appeared the “most stable” with the least amount of flickering would be used to determine the depth of suppression.
Rheostat manipulation (by the experimenter) was always in the same order. First, the amblyopic eye’s illuminance was increased by integer steps (e.g., 5 to 6, 6 to 7, etc.) where each subject was asked to identify the preferred setting by choosing between the two options presented. Illumination to the amblyopic eye was increased until a higher setting was rejected. Then, the fellow eye’s illuminance was decreased by integer steps (e.g., 5 to 4, 4 to 3, etc.) in the same manner until a lower setting was rejected. Depth of suppression was calculated as the illuminance of the fellow eye subtracted from the illuminance of the amblyopic eye (log Lux
amblyopic eye − log Lux
fellow eye), as demonstrated in
Figure 2.
Suppression was measured for each pair of targets, resulting in six measures of depth of suppression for each subject (2 target types × 3 stimulus sizes). Targets were measured in sequential order for all subjects with all first-degree targets measured first, in order from largest to smallest angular sizes, and then all second-degree targets measured in order from largest to smallest angular sizes. This order of testing was chosen as it corresponds to the order typically performed in clinical testing [
32].
For both target types, if a subject was unable to achieve the correct fusional response (e.g., soldier centered in the house or rabbit with both flowers and tail), then illumination was increased to 10 for the amblyopic eye and decreased to 0 for the fellow eye. If this still did not result in the perception of the suppressed feature, 0 and 10 were used to calculate the depth of suppression, even though suppression was still present. While arbitrarily assigning “10/0” is an overestimation of the subject’s ability to overcome suppression, we decided to perform this in order to include his/her data in our analysis.
2.4. Worth 4 Dot
Apparatus and Stimuli
Testing of suppression was performed with the Worth 4 Dot flashlight (Bernell, Mishawaka, IN, USA). This commercially available flashlight has four circular targets arranged in a diamond pattern. The overall height and width of the diamond (from outside edge to outside edge) was 35 mm, while the diameter of each dot was 6 mm. Thus, at 40 cm, the visual angle of the entire diamond subtended approximately 5°, with each dot subtending an angle of approximately 0.859°. These angular sizes decreased to approximately 0.668° and 0.115°, respectively, when the target was placed at 3 m.
2.5. Measurement of Depth of Suppression with the Worth 4 Dot
Depth of suppression was measured in a manner that is consistent with the clinical setting, and in all instances, Worth 4 Dot testing was completed after Synoptophore testing. Subjects were seated and shown the flashlight while wearing red/green glasses with the red lens over the right eye. Starting at a viewing distance of 40 cm with the room fully illuminated, subjects were asked to report the following observations: how many lights they saw, what colors they were, if all lights were of equal brightness, if lights were present the entire time or disappearing at times, and whether any of the lights appeared “cut-off” or had parts missing. If a subject reported unequal brightness, then the fellow eye was occluded, and the subject was asked if the brightness of the remaining lights, viewed by the amblyopic eye, changed. If they got brighter, then our assumption was that unequal brightness during the binocular viewing condition was due to underlying suppression and not uneven filter transmission. Thus, a partial suppression categorization was assigned when subjects reported unequal brightness in all four lights, with the amblyopic eye’s lights dimmer. Other categorizations of partial suppression are reported in
Table 2, as well as how no suppression and total suppression were defined.
If a subject reported any other response besides “no suppression,” loose prisms were held over the amblyopic eye to determine if compensating for a subject’s misalignment in free space altered their suppression response. The prism power demonstrated was determined based on the subject’s cover test at that particular viewing distance. If this “corrective” prism caused the subject to experience diplopia when they previously had not, then a different prism was selected to view through based on the subject’s subjective angle from Synoptophore testing. For our analysis, the “best” response was used, e.g., if a subject reported unequal brightness without prism and then equal brightness with, a categorization of “no suppression” was used for that particular testing distance. This prism procedure may not always be adopted in the clinical setting, as some clinicians may only be interested in the habitual viewing condition. However, the prism for motor alignment was indicated to better compare the Worth 4 Dot findings to the Synoptophore, where depth of suppression measures were taken in a manner in which the manifest deviation was compensated.
After completing testing at 40 cm with full room illumination, the lights were turned off, and testing was repeated at 40 cm in dim illumination. The testing distance then changed to 3 m with the lights back on and finally concluded at 3 m with the lights turned off. The testing sequence was the same for all subjects and was completed in the order described here: near/light, near/dark, distance/light, distance/dark. This sequence was chosen as it best matched the sequence tested in the Synoptophore (with larger visual angle targets measured first) and follows the clinical convention for Worth 4 Dot testing, in which room illumination is dimmed following an abnormal response to elicit a potential normal response.
2.6. Clinical Measures of Other Visual Functions
Distance visual acuity was measured with a Revised ETDRS chart (Precision Vision, Woodstock, IL, USA) at 3 m, with luminance set to 160 cd/m2 per manufacturer’s recommendation, and a logMAR acuity was calculated through letter scoring. Contour stereopsis (Worth’s third level of fusion) was measured with the Randot stereo test book (Stereo Optical, Chicago, IL, USA) at 40 cm, whose measurable range of binocular disparity extends from 400 to 20 arc sec. The Stereofly stereo test book (Stereo Optical, Chicago, IL, USA), whose maximum disparity is 3500 arc sec at 40 cm, was used to measure subjects who could not perceive stereopsis with the Randot stereo test book. Measurements of stereopsis were converted to log arc sec, with subjects reporting no stereopsis assigned an arbitrary value of 4 log arc sec. A cover test with prism neutralization was performed to assess ocular alignment. Additionally, all subjects underwent a comprehensive optometric examination performed by the first author.
2.7. Statistical Analysis
Nonparametric testing was used for analysis, as data did not fall into a normal distribution. To examine whether there were significant differences found depending on each of the testing conditions, Friedman’s test (a nonparametric equivalent of repeated measures ANOVA) was used. The Wilcoxon signed-rank test was then used to conduct pair comparison testing with the Bonferroni correction factor applied. To investigate the correlation between the depths of suppression measured with the Synoptophore versus the Worth 4 Dot, Kendall’s tau-b correlation coefficient was calculated, with the Worth 4 Dot data treated as an ordinal variable. To examine whether there was a significant difference in the depth of suppression depending on amblyopic sub-group, the nonparametric Mann–Whitney U testing was used. To investigate the correlation between depth of suppression and the other clinical functions of visual acuity and stereoacuity, Kendall’s tau-b correlation coefficient was utilized again, this time with all variables treated as continuous. Figures throughout
Section 3 have significant pair comparisons marked with a bracket and asterisk(s) using the following convention: significance ≤ 0.05 is marked with one asterisk, significance ≤ 0.01 is marked with two asterisks, and significance ≤ 0.001 is marked with three asterisks.
4. Discussion
The Synoptophore is commercially available to clinicians and is used to evaluate the more complex facets of the binocular visual system. It is a time-tested clinical instrument that has been used by clinicians for over a century. In addition to the instrument itself, all target stimuli used for this study were manufactured by Haag-Streit and, as such, readily provide for the normative standard to evaluate data obtained among different clinics. However, there is little research on the specifications of the instrumentation outside of the manual provided by the manufacturer, which lacks details about the illuminance output at each setting. One of our goals was to extend the utility of the Synoptophore by quantifying the illuminance levels to help guide clinicians in their use of the instrument for precise quantitative measures of binocular functions.
Our analysis of the Synoptophore’s illumination system revealed a mostly log-linear progression between integer markings. Therefore, with our particular model of the instrument, if a patient has a two integer difference between the eyes, then there is an approximately 0.3 log unit difference between the eyes; twice the brightness is needed to overcome the interocular suppression. We are, of course, cognizant of the likelihood that not all models of Synoptophore would measure the same illuminance values. For instance, the light bulbs’ brightness changes with instrument age, and replacement light bulbs or rheostats might have different specifications. However, these hurdles could be mitigated by maintaining the Synoptophore with the factory-supplied parts. This will likely ensure the log-linearity of the illuminance outputs, making the quantification of suppression straightforward.
In our study, we measured suppression magnitudes with the targets provided by the manufacturer, as in standard practice, with a goal of identifying which target elicited the greatest suppression in our subjects. These targets differed in type (first- vs. second-degree fusion) and size (stimulating varying retinal eccentricity). We found the general trend that the small target sizes elicited the greatest depth of suppression. With the Synoptophore, this was achieved with the smallest angular-sized targets for each type (soldier size: 2.5 × 0.5°; rabbit size: 2.5 × 2.5°). With the Worth 4 Dot, this was achieved when the target was viewed at a 3 m distance (diamond size: 0.668 × 0.668°). This corresponds with the clinical notion of central suppression versus peripheral suppression. It has been documented that suppression characteristics can be altered depending on retinal location [
8,
16,
33,
34]. In general, targets involving the central part of the retina, particularly the fovea and the retinal location where the object of regard falls, in cases of strabismus, elicit suppression more frequently/excessively than more peripheral targets. As the target sizes decreased in our study, they progressively stimulated the foveal region of each eye relative to the more peripheral retinal regions. When measured in progression, as in our study, the depth of suppression for each target type and size provided extensive information about an individual’s sensory deficits. However, by identifying the target(s) that elicited the most suppression, clinicians seeking to extrapolate depth of suppression information through minimal amounts of measurement should consider testing with small first- and second-degree Synoptophore targets and Worth 4 Dot at a distance, as the patient response with this target will best indicate the maximum amount of suppression they must overcome.
The significant correlation between these small Synoptophore targets and the Worth 4 Dot at a distance is not surprising, especially considering the discussion of central suppression above. By correlating our measures from the Synoptophore with the Worth 4 Dot findings for each subject, we are able to validate our protocol with the Synoptophore through comparison to a widely used clinical tool. Qualitatively describing suppression with the Worth 4 Dot as none, partial, and total also extended the usefulness of this clinical tool by differentiating presumed normal responses (four dots are seen) with more nuance (e.g., unequal brightness or predominance of the fellow eye for the commonly seen dot). Even with this extra level of differentiation, there was still more sensitivity seen with the Synoptophore measures; as seen in
Figure 5, when subjects responded with no suppression with Worth 4 Dot, they reported suppression with the Synoptophore, unveiling suppression that was unmeasurable by the former test.
The subjects in our study were adults who had previously been treated for amblyopia. They were classified as strabismic or non-strabismic (anisometropic) based on the suspected origin of their amblyopia. We found the overall depth of suppression between these two groups to be different. Namely, the strabismic subjects demonstrated an average depth of suppression that was two to three times that of non-strabismic subjects. This finding of a larger depth of suppression in the strabismic group is consistent with most basic psychophysical observations of more compromised sensorimotor functions. For example, McKee et al. (2003) found that non-binocular amblyopes (those with strabismus) tended to have worse optotype acuity and Vernier acuity, for a given level of grating acuity, than those with residual binocular function [
7]. In another study, McKee et al. (2016) found that strabismic amblyopes had longer saccadic latency than non-strabismic amblyopes [
35].
There was a strong correlation between suppression magnitudes and clinical measures; as suppression increased, performance on clinical tests decreased. Subjects with greater depths of suppression had greater interocular difference in visual acuity and poorer stereoacuity than subjects with a lesser depth of suppression. Correlations between suppression and clinical measures of visual acuity and stereoacuity have also been reported previously [
36,
37]. The observation of reduced stereopsis is not unique to amblyopia, as we have shown the same relationship in subjects with clinically normal vision. Specifically, we showed that subjects with higher magnitudes of sensory eye dominance, due to a larger depth of suppression, had a higher stereo threshold and stereo response time [
15,
16,
17]. In finding that depth of suppression measures from the Synoptophore endorse previously found relationships between other clinical measures and suppression, it supports the use of the Synoptophore as a clinical instrument to quantify suppression in addition to other newly proposed technologies [
22,
23], with the added benefit that many working in binocular vision clinics already have access to it.
The goal of our investigation into the Synoptophore was to explore if use of the device could be extended to provide a quantitative measure of suppression in amblyopia that can be utilized by clinicians. We found the answer in the affirmative and also showed, in using a quantifiable clinical instrument, that the extent of suppression is correlated to deficits in other visual functions. We suggest that measuring the depth of suppression could better diagnose an individual’s extent of amblyopia and then be used as another metric to help guide treatment. Additionally, monitoring the depth of suppression during treatment may be more meaningful than a monocular measure, such as visual acuity, as it could better reflect the excessive inhibition in amblyopia. While monocular measures are important, binocular measures more directly address the causative nature of amblyopia, a binocular imbalance during vision development.